Home > Boards > Free Zone > All Fundamentals > ALERTS, CHARTS, & HOT STOCKS

$ARFXF on fire after biogen news

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Gbathat Member Profile
 
Followed By 10
Posts 1,330
Boards Moderated 0
Alias Born 06/05/07
160x600 placeholder
Gbathat   Monday, 06/07/21 02:02:11 PM
Re: None
Post # of 173202 
$ARFXF on fire after biogen news

still a long way to run

ProMIS Neurosciences makes a more selective and specific antibody than Biogen's aducanumab. Aducanumab is limited by brain swelling effects but has shown some clinical benefit, hence FDA approval today and a boost in their market cap by about $10-15 BILLION in just an hour.

ARFXF (ProMIS) makes PMN310 which can be dosed at higher levels. The company has been pre-phase I for a while, and shareholders were told that PHI funding was contingent on FDA approval of aducanumab.

Here's the real kicker... PMN's market cap is only $60M... which is peanuts compared to the market opportunity.

$ARFXF

glta

God grant me the serenity to deal with the things I cannot change; courage to change the things I can and should; and wisdom to know the difference.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences